Discover how a 13-year-old boy with Glycogen Storage Disorder Type 1A manages his rare condition by drinking cornstarch water ...

The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

PRIME Marine has released a set of feature enhancements to its Vessel Management System, introducing CMS-aligned ...

Malawi breaking news publishing 24 hours a day news about Malawi, Malawi Business, Malawi Tourism, Malawi Politics, Malawi News ...

AP31969 is a novel, first-in-class, oral SK ion channel inhibitor intended for rhythm control of atrial fibrillation and has recently completed Phase 1 in healthy volunteersPhase 2 trial will assess ...

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

China’s Wangu field in Hunan logs 40 veins near 2,000 m; models reach 3,000 m, with 300 already indicated and a valuation ...

To mark Nollaig na mBan, Suzanne Harrington looks at how work deadlines, digital overload, domestic responsibilities, disrupted sleep rhythms, and poor diet often leave women running on stress hormone ...

The press release issued by Tuktu Resources Ltd. (TSXV: TUK) (“Tuktu” or the “Company”) dated January 7, 2026 (the “Press ...

The press release issued by Tuktu Resources Ltd. (TSXV: TUK) ("Tuktu" or the "Company") dated January 7, 2026 (the "Press Release"), in our opinion ...